• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor.β1 肾上腺素受体拮抗剂结合结构中观察到的螺旋 6 区两种不同构象。
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8228-32. doi: 10.1073/pnas.1100185108. Epub 2011 May 3.
2
Structure of a beta1-adrenergic G-protein-coupled receptor.β1-肾上腺素能G蛋白偶联受体的结构
Nature. 2008 Jul 24;454(7203):486-91. doi: 10.1038/nature07101. Epub 2008 Jun 25.
3
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.激动剂和部分激动剂在β(1)-肾上腺素能受体上作用的结构基础。
Nature. 2011 Jan 13;469(7329):241-4. doi: 10.1038/nature09746.
4
Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.野生型β1和β2肾上腺素能受体分子动力学模拟中“离子锁”形成的观察
Biochemistry. 2009 Jun 9;48(22):4789-97. doi: 10.1021/bi900299f.
5
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.β2肾上腺素能受体两种不同失活构象的鉴定协调了结构与生化观察结果。
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94. doi: 10.1073/pnas.0811065106. Epub 2009 Mar 3.
6
Engineering an ultra-thermostable β(1)-adrenoceptor.工程化超稳定β(1)-肾上腺素能受体。
J Mol Biol. 2011 Oct 28;413(3):628-38. doi: 10.1016/j.jmb.2011.08.057. Epub 2011 Sep 6.
7
Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor.野生型和突变型β1-肾上腺素能受体构象稳定性的结构见解。
Biophys J. 2010 Jul 21;99(2):568-77. doi: 10.1016/j.bpj.2010.04.075.
8
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
9
Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.基于结构的 G 蛋白偶联受体配体功能预测:β-肾上腺素能受体案例研究。
J Chem Inf Model. 2015 May 26;55(5):1045-61. doi: 10.1021/acs.jcim.5b00066. Epub 2015 May 1.
10
Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.NMR 揭示了β1-肾上腺素能受体中的变构信号转导网络。
Nature. 2016 Feb 11;530(7589):237-41. doi: 10.1038/nature16577. Epub 2016 Feb 3.

引用本文的文献

1
Clinical and computational exploration of red date fruit vinegar: synergistic effects on cardiovascular and type 2 diabetes pathways.红枣果醋的临床与计算探索:对心血管和2型糖尿病通路的协同作用
Front Nutr. 2025 Jul 14;12:1557733. doi: 10.3389/fnut.2025.1557733. eCollection 2025.
2
LIGYSIS-web: a resource for the analysis of protein-ligand binding sites.LIGYSIS-web:一个用于分析蛋白质-配体结合位点的资源。
Nucleic Acids Res. 2025 Jul 7;53(W1):W351-W360. doi: 10.1093/nar/gkaf411.
3
The Discovery of Novel α Adrenergic Receptor Agonists Only Coupling to Gαi/O Proteins by Virtual Screening.通过虚拟筛选发现仅与 Gαi/O 蛋白偶联的新型 α 肾上腺素能受体激动剂。
Int J Mol Sci. 2024 Jun 30;25(13):7233. doi: 10.3390/ijms25137233.
4
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.G 蛋白偶联受体-配体构象和功能分类预测。
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
5
Cellular lipids regulate the conformational ensembles of the disordered intracellular loop 3 in β2-adrenergic receptor.细胞脂质调节β2肾上腺素能受体中无序细胞内环3的构象集合。
iScience. 2024 May 23;27(6):110086. doi: 10.1016/j.isci.2024.110086. eCollection 2024 Jun 21.
6
Binding kinetics drive G protein subtype selectivity at the β-adrenergic receptor.结合动力学决定β肾上腺素能受体中 G 蛋白亚型的选择性。
Nat Commun. 2024 Feb 13;15(1):1334. doi: 10.1038/s41467-024-45680-7.
7
Molecular mechanism of GPCR spatial organization at the plasma membrane.GPCR 在质膜上空间组织的分子机制。
Nat Chem Biol. 2024 Feb;20(2):142-150. doi: 10.1038/s41589-023-01385-4. Epub 2023 Jul 17.
8
Structures of Adrenoceptors.肾上腺素能受体的结构。
Handb Exp Pharmacol. 2024;285:13-26. doi: 10.1007/164_2023_674.
9
Autoregulation of GPCR signalling through the third intracellular loop.通过第三细胞内环调节 G 蛋白偶联受体信号转导。
Nature. 2023 Mar;615(7953):734-741. doi: 10.1038/s41586-023-05789-z. Epub 2023 Mar 8.
10
The Science Behind G Protein-Coupled Receptors (GPCRs) and Their Accurate Visual Representation in Scientific Research.G蛋白偶联受体(GPCRs)背后的科学及其在科学研究中的精确视觉呈现。
J Biocommun. 2017 May 4;41(1):e6. doi: 10.5210/jbc.v41i1.7309. eCollection 2017.

本文引用的文献

1
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.
2
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.小分子和环肽拮抗剂与 CXCR4 趋化因子 GPCR 的结构。
Science. 2010 Nov 19;330(6007):1066-71. doi: 10.1126/science.1194396. Epub 2010 Oct 7.
3
Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.X 射线晶体学揭示了人β2 肾上腺素能受体反向激动剂和拮抗剂的保守结合模式。
J Am Chem Soc. 2010 Aug 25;132(33):11443-5. doi: 10.1021/ja105108q.
4
A G protein-coupled receptor at work: the rhodopsin model.工作中的 G 蛋白偶联受体:视紫红质模型。
Trends Biochem Sci. 2009 Nov;34(11):540-52. doi: 10.1016/j.tibs.2009.07.005. Epub 2009 Oct 21.
5
Engineering G protein-coupled receptors to facilitate their structure determination.工程化改造G蛋白偶联受体以促进其结构测定。
Curr Opin Struct Biol. 2009 Aug;19(4):386-95. doi: 10.1016/j.sbi.2009.07.004. Epub 2009 Aug 12.
6
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
7
Development and crystallization of a minimal thermostabilised G protein-coupled receptor.一种最小化热稳定G蛋白偶联受体的开发与结晶
Protein Expr Purif. 2009 Jun;65(2):204-13. doi: 10.1016/j.pep.2009.01.014.
8
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.β2肾上腺素能受体两种不同失活构象的鉴定协调了结构与生化观察结果。
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94. doi: 10.1073/pnas.0811065106. Epub 2009 Mar 3.
9
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.与拮抗剂结合的人A2A腺苷受体的2.6埃晶体结构。
Science. 2008 Nov 21;322(5905):1211-7. doi: 10.1126/science.1164772. Epub 2008 Oct 2.
10
Crystal structure of opsin in its G-protein-interacting conformation.视蛋白处于与G蛋白相互作用构象时的晶体结构。
Nature. 2008 Sep 25;455(7212):497-502. doi: 10.1038/nature07330.

β1 肾上腺素受体拮抗剂结合结构中观察到的螺旋 6 区两种不同构象。

Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor.

机构信息

Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8228-32. doi: 10.1073/pnas.1100185108. Epub 2011 May 3.

DOI:10.1073/pnas.1100185108
PMID:21540331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100933/
Abstract

The β(1)-adrenergic receptor (β(1)AR) is a G-protein-coupled receptor whose inactive state structure was determined using a thermostabilized mutant (β(1)AR-M23). However, it was not thought to be in a fully inactivated state because there was no salt bridge between Arg139 and Glu285 linking the cytoplasmic ends of transmembrane helices 3 and 6 (the R(3.50) - D/E(6.30) "ionic lock"). Here we compare eight new structures of β(1)AR-M23, determined from crystallographically independent molecules in four different crystals with three different antagonists bound. These structures are all in the inactive R state and show clear electron density for cytoplasmic loop 3 linking transmembrane helices 5 and 6 that had not been seen previously. Despite significantly different crystal packing interactions, there are only two distinct conformations of the cytoplasmic end of helix 6, bent and straight. In the bent conformation, the Arg139-Glu285 salt bridge is present, as in the crystal structure of dark-state rhodopsin. The straight conformation, observed in previously solved structures of β-receptors, results in the ends of helices 3 and 6 being too far apart for the ionic lock to form. In the bent conformation, the R(3.50)-E(6.30) distance is significantly longer than in rhodopsin, suggesting that the interaction is also weaker, which could explain the high basal activity in β(1)AR compared to rhodopsin. Many mutations that increase the constitutive activity of G-protein-coupled receptors are found in the bent region at the cytoplasmic end of helix 6, supporting the idea that this region plays an important role in receptor activation.

摘要

β(1)-肾上腺素能受体(β(1)AR)是一种 G 蛋白偶联受体,其非活性状态结构是使用热稳定突变体(β(1)AR-M23)确定的。然而,由于跨膜螺旋 3 和 6 的细胞质末端之间没有 Arg139 和 Glu285 之间的盐桥(连接跨膜螺旋 3 和 6 的细胞质末端的 R(3.50)-D/E(6.30)“离子锁”),因此人们认为它没有处于完全失活状态。在这里,我们比较了β(1)AR-M23 的八个新结构,这些结构是从四个不同晶体中结晶独立的分子中确定的,其中三个晶体与三种不同的拮抗剂结合。这些结构都处于非活性的 R 状态,并且清楚地显示了以前没有看到的跨膜螺旋 5 和 6 之间的细胞质环 3 的电子密度。尽管晶体堆积相互作用有很大差异,但跨膜螺旋 6 的细胞质末端只有两种不同的构象,弯曲和伸直。在弯曲构象中,存在 Arg139-Glu285 盐桥,如黑暗状态视紫红质的晶体结构。在以前解决的β-受体结构中观察到的直构象导致螺旋 3 和 6 的末端相距太远,无法形成离子锁。在弯曲构象中,R(3.50)-E(6.30)距离明显长于视紫红质,表明相互作用也较弱,这可以解释与视紫红质相比,β(1)AR 的基础活性较高。许多增加 G 蛋白偶联受体组成型活性的突变发生在跨膜螺旋 6 的细胞质末端的弯曲区域,这支持了该区域在受体激活中起重要作用的观点。